Ikarian Capital, LLC Seres Therapeutics, Inc. Call Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $5.17 Million - $6.82 Million	-280,000 Reduced 35.9%	500,000 $11.9 Million
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $7.75 Million - $12.7 Million	438,900 Added 128.67%	780,000 $16.1 Million
Q4 2020 Feb 12, 2021	SELL	$23.25 - $37.73 $9.8 Million - $15.9 Million	-421,300 Reduced 55.26%	341,100 $8.36 Million
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $1.92 Million - $14.7 Million	512,400 Added 204.96%	762,400 $21.6 Million
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $760,000 - $1.55 Million	250,000 New	250,000 $1.19 Million

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $118M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.